Literature DB >> 8943232

Processing of beta-amyloid precursor protein by cathepsin D.

J Higaki1, R Catalano, A W Guzzetta, D Quon, J F Navé, C Tarnus, H D'Orchymont, B Cordell.   

Abstract

The events leading to the formation of beta-amyloid (betaA4) from its precursor (betaAPP) involve proteolytic cleavages that produce the amino and carboxyl termini of betaA4. The enzyme activities responsible for these cleavages have been termed beta- and gamma-secretase, respectively, although these protease(s) have not been identified. Since betaA4 is known to possess heterogeneity at both the amino and carboxyl termini, beta- and gamma-secretases may actually be a collection of proteolytic activities or perhaps a single proteolytic enzyme with broad amino acid specificity. We investigated the role of cathepsin D in the processing of betaAPP since this enzyme has been widely proposed as a gamma-secretase candidate. Treatment of a synthetic peptide that spans the gamma-secretase site of betaAPP with human cathepsin D resulted in the cleavage of this substrate at Ala42-Thr43. A sensitive liquid chromatography/mass spectrometry technique was also developed to further investigate the ability of cathepsin D to process longer recombinant betaAPP substrates (156 and 100 amino acids of betaAPP carboxyl terminus) in vitro. The precise cathepsin D cleavage sites within these recombinant betaAPP substrates were identified using this technique. Both recombinant substrates were cleaved at the following sites: Leu49-Val50, Asp68-Ala69, Phe93-Phe94. No cleavages were observed at putative gamma-secretase sites: Val40-Ile41 or Ala42-Thr43, suggesting that cathepsin D is not gamma-secretase as defined by these betaA4 termini. Under conditions where the betaAPP156 substrate was first denatured prior to cathepsin D digestion, two additional cleavage sites near the amino terminus of betaA4, Glu-3-Val-2 and Glu3-Phe4, were observed, indicating that cathepsin D cleavage of betaAPP is influenced by the structural integrity of the substrate. Taken together, these results indicate that in vitro, cathepsin D is unlikely to function as gamma-secretase; however, the ability of this enzyme to efficiently cleave betaAPP substrates at nonamyloidogenic sites within the molecule may reflect a role in betaAPP catabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943232     DOI: 10.1074/jbc.271.50.31885

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis.

Authors:  Wendy E Kaman; Fabiano Galassi; Johannes J de Soet; Sergio Bizzarro; Bruno G Loos; Enno C I Veerman; Alex van Belkum; John P Hays; Floris J Bikker
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  A novel approach for characterization of cathepsin D protease and its effect on tau and β-amyloid proteins.

Authors:  Mazhar Malik; Michael D Fenko; Ashfaq M Sheikh; Guang Wen; Xiaohong Li
Journal:  Neurochem Res       Date:  2011-01-26       Impact factor: 3.996

4.  Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

Authors:  Christopher D Aluise; Renã A Sowell Robinson; Tina L Beckett; M Paul Murphy; Jian Cai; William M Pierce; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-04-23       Impact factor: 5.996

5.  Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet.

Authors:  Xuesong Chen; John F Wagener; Daniel H Morgan; Liang Hui; Othman Ghribi; Jonathan D Geiger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies.

Authors:  Mohammad A Rahman; Benjamin J Patters; Sunitha Kodidela; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-06       Impact factor: 4.147

7.  Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.

Authors:  Liang Hui; Xuesong Chen; Jonathan D Geiger
Journal:  Life Sci       Date:  2012-05-11       Impact factor: 5.037

Review 8.  Protein truncation as a common denominator of human neurodegenerative foldopathies.

Authors:  Santosh Jadhav; Norbert Zilka; Michal Novak
Journal:  Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.590

9.  Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.

Authors:  Patrick A Lewis; Francesca Properzi; Kanella Prodromidou; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

10.  Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.

Authors:  Qingli Xiao; Ping Yan; Xiucui Ma; Haiyan Liu; Ronaldo Perez; Alec Zhu; Ernesto Gonzales; Danielle L Tripoli; Leah Czerniewski; Andrea Ballabio; John R Cirrito; Abhinav Diwan; Jin-Moo Lee
Journal:  J Neurosci       Date:  2015-09-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.